Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
28 10 2023
28 10 2023
Historique:
received:
06
02
2023
accepted:
17
10
2023
medline:
30
10
2023
pubmed:
29
10
2023
entrez:
29
10
2023
Statut:
epublish
Résumé
The mortality impact of COVID-19 in Africa remains controversial because most countries lack vital registration. We analysed excess mortality in Kilifi Health and Demographic Surveillance System, Kenya, using 9 years of baseline data. SARS-CoV-2 seroprevalence studies suggest most adults here were infected before May 2022. During 5 waves of COVID-19 (April 2020-May 2022) an overall excess mortality of 4.8% (95% PI 1.2%, 9.4%) concealed a significant excess (11.6%, 95% PI 5.9%, 18.9%) among older adults ( ≥ 65 years) and a deficit among children aged 1-14 years (-7.7%, 95% PI -20.9%, 6.9%). The excess mortality rate for January 2020-December 2021, age-standardised to the Kenyan population, was 27.4/100,000 person-years (95% CI 23.2-31.6). In Coastal Kenya, excess mortality during the pandemic was substantially lower than in most high-income countries but the significant excess mortality in older adults emphasizes the value of achieving high vaccine coverage in this risk group.
Identifiants
pubmed: 37898630
doi: 10.1038/s41467-023-42615-6
pii: 10.1038/s41467-023-42615-6
pmc: PMC10613220
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6879Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Int J Infect Dis. 2023 Mar;128:61-68
pubmed: 36566776
Influenza Other Respir Viruses. 2023 Sep;17(9):e13173
pubmed: 37752065
Int J Epidemiol. 2012 Jun;41(3):650-7
pubmed: 22544844
Nature. 2023 Jan;613(7942):130-137
pubmed: 36517599
Scand J Public Health Suppl. 2007 Aug;69:35-44
pubmed: 17676501
PLoS One. 2021 Jan 13;16(1):e0244474
pubmed: 33439880
Glob Health Action. 2014 Oct 29;7:25593
pubmed: 25377342
Lancet. 2020 May 2;395(10234):e81
pubmed: 32333839
Nat Commun. 2021 Jun 25;12(1):3966
pubmed: 34172732
PLoS Med. 2022 Nov 10;19(11):e1004107
pubmed: 36355774
Lancet Digit Health. 2021 Jun;3(6):e360-e370
pubmed: 34045002
PLOS Glob Public Health. 2022 Aug 18;2(8):e0000883
pubmed: 36962821
Int J Environ Res Public Health. 2021 Apr 12;18(8):
pubmed: 33921217
Nat Med. 2022 Mar;28(3):583-590
pubmed: 35132265
BMJ. 2022 Aug 2;378:e070695
pubmed: 35918098
Lancet. 2022 Apr 16;399(10334):1513-1536
pubmed: 35279232
Lancet Glob Health. 2022 Aug;10(8):e1099-e1114
pubmed: 35659911
Bull World Health Organ. 2021 Jan 01;99(1):19-33F
pubmed: 33716331
Int J Public Health. 2021 Oct 05;66:1604249
pubmed: 34675760
Eur J Epidemiol. 2021 Jun;36(6):581-588
pubmed: 34322831
BMJ. 2021 May 19;373:n1137
pubmed: 34011491
Science. 2021 Nov 19;374(6570):989-994
pubmed: 34618602
PLoS One. 2020 Oct 9;15(10):e0240286
pubmed: 33035253
Soc Sci Med. 2016 Sep;164:59-73
pubmed: 27471131
AAS Open Res. 2020 Apr 17;3:4
pubmed: 32399515
Wellcome Open Res. 2023 Feb 17;6:327
pubmed: 37416502
Lancet Reg Health Am. 2021 Oct;2:None
pubmed: 34693394